×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| IND-SWIFT LABORATORIES LTD. | 224.77 | 0.06 | 86.65 | 0.00 | 553.0 | 6.68 |
| MEDICO REMEDIES LIMITED | 409.15 | 26.20 | 394.90 | 0.32 | 545 | 61.6 |
| Prevest Denpro Limited | NA | NA | NA | NA | 543 | 30.8 |
Ind-Swift Laboratories Ltd., with Security Code 532305, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 271.5 | 287.5 | 302.4 | 290.4 | 299.0 | 270.3 | 276.2 | 381.7 | 30.4 | 2.7 |
| Expenses | 218.5 | 230.7 | 246.5 | 234.1 | 239.2 | 206.9 | 222.5 | 286.3 | 35.0 | 14.7 |
| Operating Profit | 53.0 | 56.9 | 55.9 | 56.3 | 59.8 | 63.4 | 53.8 | 95.5 | -4.5 | -12.0 |
| OPM % | 19.51% | 19.77% | 18.49% | 19.4% | 20% | 23.46% | 19.48% | 25.01% | -14.88% | -443.39% |
| Other Income | 7.4 | 7.5 | 8.4 | -16.7 | 5.6 | 7.4 | 7.1 | 411.8 | 11.1 | 12.9 |
| Interest | 24.0 | 24.0 | 22.4 | 21.8 | 20.4 | 21.1 | 21.1 | 11.5 | 0.2 | 0.4 |
| Depreciation | 16.3 | 16.4 | 15.4 | 9.3 | 13.9 | 13.2 | 13.6 | 12.7 | 0.3 | 0.2 |
| Profit before tax | 20.1 | 24.0 | 26.5 | 35.2 | 31.1 | 36.5 | 26.3 | 96.6 | 6.2 | 0.3 |
| Tax % | 0% | 0% | 10.4% | 460.5% | 17.5% | 17.5% | 17.7% | 27.6% | 0% | 0% |
| Net Profit | 20.1 | 24.0 | 29.2 | -30.9 | 17.1 | 30.1 | 21.7 | 349.6 | 6.2 | 0.3 |
| EPS in Rs | 3.41 | 4.07 | 4.95 | -5.23 | 2.89 | 5.09 | 3.66 | 59.17 | 1.05 | 0.05 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 310.2 | 312.7 | 304.2 | 310.3 | 289.7 | 287.5 | 393.3 | 33.2 | 12.0 | 8.7 |
| Expenses | 251.5 | 259.0 | 239.6 | 250.2 | 224.2 | 236.4 | 407.7 | 43.0 | 23.8 | 23.2 |
| Operating Profit | 58.8 | 53.6 | 64.6 | 60.1 | 65.5 | 51.2 | -14.4 | -9.8 | -11.8 | -14.5 |
| OPM % | 18.9% | 17.2% | 21.2% | 19.4% | 22.6% | 17.8% | -3.6% | -29.6% | -98.6% | -167.7% |
| Other Income | 7.5 | 8.4 | -16.4 | 5.6 | 7.4 | 7.1 | 411.8 | 11.1 | 13.0 | 13.8 |
| Interest | 24.0 | 22.4 | 21.8 | 20.4 | 21.1 | 21.1 | 11.5 | 0.2 | 0.4 | 0.1 |
| Depreciation | 16.4 | 15.4 | 9.3 | 13.9 | 13.2 | 13.6 | 12.7 | 0.3 | 0.2 | 0.2 |
| Profit before tax | 25.9 | 24.2 | 43.7 | 31.5 | 38.6 | 23.7 | -13.3 | 0.9 | 0.6 | -1.1 |
| Tax % | 2.2% | 13.4% | 239.9% | 17.8% | 17.9% | 17.9% | 36% | 3% | 31.7% | -99.5% |
| Net Profit | 25.3 | 27.5 | -24.1 | 17.2 | 31.7 | 19.4 | 238.9 | 0.9 | 0.4 | 0.0 |
| EPS in Rs | 4 | 4 | -4 | 2 | 5 | 3 | 40 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | -63% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 48% |
| 3 Years: | 222% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 35% |
| 3 Years: | 11% |
| 1 Year: | -17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | -62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 42% |
| 3 Years: | 260% |
| TTM: | 188% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 35% |
| 3 Years: | 11% |
| 1 Year: | -17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|